84 related articles for article (PubMed ID: 3965693)
1. Neuropharmacological characterization of fragment B from tetanus toxin.
Simpson LL; Hoch DH
J Pharmacol Exp Ther; 1985 Jan; 232(1):223-7. PubMed ID: 3965693
[TBL] [Abstract][Full Text] [Related]
2. Fragment C of tetanus toxin antagonizes the neuromuscular blocking properties of native tetanus toxin.
Simpson LL
J Pharmacol Exp Ther; 1984 Mar; 228(3):600-4. PubMed ID: 6707911
[TBL] [Abstract][Full Text] [Related]
3. The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin.
Simpson LL
J Pharmacol Exp Ther; 1984 Apr; 229(1):182-7. PubMed ID: 6707933
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological experiments on the binding and internalization of the 50,000 dalton carboxyterminus of tetanus toxin at the cholinergic neuromuscular junction.
Simpson LL
J Pharmacol Exp Ther; 1985 Jul; 234(1):100-5. PubMed ID: 2409271
[TBL] [Abstract][Full Text] [Related]
5. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins.
Simpson LL
J Pharmacol Exp Ther; 1988 Jun; 245(3):867-72. PubMed ID: 2455038
[TBL] [Abstract][Full Text] [Related]
6. Isolation and characterization of a novel human monoclonal antibody that neutralizes tetanus toxin.
Simpson LL; Lake P; Kozaki S
J Pharmacol Exp Ther; 1990 Jul; 254(1):98-103. PubMed ID: 1694896
[TBL] [Abstract][Full Text] [Related]
7. Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin.
Simpson LL; Coffield JA; Bakry N
J Pharmacol Exp Ther; 1993 Nov; 267(2):720-7. PubMed ID: 8246147
[TBL] [Abstract][Full Text] [Related]
8. Tetanus toxin and neuronal membranes: the relationship between binding and toxicity.
Bakry N; Kamata Y; Sorensen R; Simpson LL
J Pharmacol Exp Ther; 1991 Aug; 258(2):613-9. PubMed ID: 1865360
[TBL] [Abstract][Full Text] [Related]
9. Isolation and purification by high performance liquid chromatography of a tetanus toxin fragment (fragment [A-B]) derived from mildly papain-treated toxin.
Ozutsumi K; Lei DL; Sugimoto N; Matsuda M
Toxicon; 1989; 27(9):1055-7. PubMed ID: 2799836
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic experiments on the interaction between crotoxin and the mammalian neuromuscular junction.
Trivedi S; Kaiser II; Tanaka M; Simpson LL
J Pharmacol Exp Ther; 1989 Nov; 251(2):490-6. PubMed ID: 2553923
[TBL] [Abstract][Full Text] [Related]
11. Isolation, purification, and characterization of fragment B, the NH2-terminal half of the heavy chain of tetanus toxin.
Matsuda M; Lei DL; Sugimoto N; Ozutsumi K; Okabe T
Infect Immun; 1989 Nov; 57(11):3588-93. PubMed ID: 2478476
[TBL] [Abstract][Full Text] [Related]
12. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
Simpson LL; Dasgupta BR
J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
[TBL] [Abstract][Full Text] [Related]
13. Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins.
Simpson LL
J Pharmacol Exp Ther; 1983 Jun; 225(3):546-52. PubMed ID: 6864519
[TBL] [Abstract][Full Text] [Related]
14. Neuromuscular activity of BaTX, a presynaptic basic PLA2 isolated from Bothrops alternatus snake venom.
Ponce-Soto LA; Barros JC; Marangoni S; Hernandez S; Dal Belo CA; Corrado AP; Hyslop S; Rodrigues-Simioni L
Comp Biochem Physiol C Toxicol Pharmacol; 2009 Aug; 150(2):291-7. PubMed ID: 19463969
[TBL] [Abstract][Full Text] [Related]
15. On-chip native gel electrophoresis-based immunoassays for tetanus antibody and toxin.
Herr AE; Throckmorton DJ; Davenport AA; Singh AK
Anal Chem; 2005 Jan; 77(2):585-90. PubMed ID: 15649057
[TBL] [Abstract][Full Text] [Related]
16. Neutralization of tetanus toxin by human monoclonal antibodies directed against tetanus toxin fragment C.
Gustafsson B; Whitmore E; Tiru M
Hybridoma; 1993 Dec; 12(6):699-708. PubMed ID: 8288271
[TBL] [Abstract][Full Text] [Related]
17. Use of monoclonal antibodies as probes for the structure and biological activity of botulinum neurotoxin.
Simpson LL; Kamata Y; Kozaki S
J Pharmacol Exp Ther; 1990 Oct; 255(1):227-32. PubMed ID: 2213557
[TBL] [Abstract][Full Text] [Related]
18. Studies on the antibody composition and neutralizing activity of tetanus antitoxin sera from various species of animals in relation to the antigenic substructure of the tetanus toxin molecule.
Matsuda M; Makinaga G; Hirai T
Biken J; 1983 Dec; 26(4):133-43. PubMed ID: 6204634
[TBL] [Abstract][Full Text] [Related]
19. Internalization of a GFP-tetanus toxin C-terminal fragment fusion protein at mature mouse neuromuscular junctions.
Roux S; Colasante C; Saint Cloment C; Barbier J; Curie T; Girard E; Molgó J; Brûlet P
Mol Cell Neurosci; 2005 Sep; 30(1):79-89. PubMed ID: 16023367
[TBL] [Abstract][Full Text] [Related]
20. [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies].
Burkin MA; Sviridov VV; Perelygina OV
Prikl Biokhim Mikrobiol; 2004; 40(4):478-84. PubMed ID: 15455723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
